seroprevalence
Showing NaN - NaN of 1
Hepatitis B, Immune Response, Seroprevalence Trial in Nanning (HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen,
Completed
- Hepatitis B
- +2 more
- HBV vaccine (Engerix-B, recombinant hepatitis B surface antigen, 20µg/mL/vial, GlaxoSmithKline, Belgium)
-
Nanning, Guangxi, ChinaGuangxi Centers for Disease Control and Prevention
May 23, 2013